About: Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	Updated follow-up of the multicenter clinical study - Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: impact of subsequent therapy in the phase III VISTA trial Updated follow-up of the multicenter clinical study - Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: impact of subsequent therapy in the phase III VISTA trial (en)
Title	Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial (en)
skos:prefLabel	Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial (en)
skos:notation	RIV/00064165:_____/10:7566!RIV11-MZ0-00064165
http://linked.open...avai/riv/aktivita	I Z
http://linked.open...avai/riv/aktivity	I, Z(MSM0021620808)
http://linked.open...iv/cisloPeriodika	13
http://linked.open...vai/riv/dodaniDat	2011
http://linked.open...aciTvurceVysledku	Špička, Ivan
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Všeobecná fakultní nemocnice v Praze / (nerozlišená součást)
http://linked.open...dnocenehoVysledku	249148
http://linked.open...ai/riv/idVysledku	RIV/00064165:_____/10:7566
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	INTERNATIONAL STAGING SYSTEM; STEM-CELL TRANSPLANTATION; NEWLY-DIAGNOSED MYELOMA; ELDERLY-PATIENTS; PERIPHERAL NEUROPATHY; IMPROVED SURVIVAL; PROGRESSION-FREE; YOUNGER PATIENTS; THALIDOMIDE; EFFICACY (en)
http://linked.open.../riv/klicoveSlovo	THALIDOMIDE ELDERLY-PATIENTS IMPROVED SURVIVAL INTERNATIONAL STAGING SYSTEM NEWLY-DIAGNOSED MYELOMA PERIPHERAL NEUROPATHY PROGRESSION-FREE YOUNGER PATIENTS STEM-CELL TRANSPLANTATION EFFICACY
http://linked.open...odStatuVydavatele	US - Spojené státy americké
http://linked.open...ontrolniKodProRIV	[1213BF51B736]
http://linked.open...i/riv/nazevZdroje	Journal of Clinical Oncology
http://linked.open...in/vavai/riv/obor	FD
http://linked.open...ichTvurcuVysledku	1 (xsd:int)
http://linked.open...cetTvurcuVysledku	20 (xsd:int)
http://linked.open...UplatneniVysledku	2010
http://linked.open...v/svazekPeriodika	28
http://linked.open...iv/tvurceVysledku	Shpilberg, O. Špička, Ivan Dimopoulos, M. A. Kropff, M. Mateos, M. Khuageva, NK Richardson, PG Schlag, R.
http://linked.open...ain/vavai/riv/wos	000277180300022
http://linked.open...n/vavai/riv/zamer	Molekulárně biologické, genetické a epigenetické aspekty vzniku a rozvoje modelových tumorů dospělého věku. Význam pro epidemiologii, časnou diagnostiku a léčbu
issn	0732-183X
number of pages	8 (xsd:int)

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 112 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software